However, clinical validity – whether recognizing disease-associated variants by sequencing (e.g., of the CFTR locus) predicts the disease (e.g., cystic fibrosis) – is often a more difficult question to resolve than analytical validity. This evidence concerns the gene CFTR and cystic fibrosis.